BusinessCann
BusinessCann · page 8
- Press releases
Khiron Achieves United Kingdom Cannabis Sales Volume Growth Of 240% In Q1 2022
KHIRON Life Sciences Corp. (“Khiron” or the “Company”) (TSXV: KHRN) (OTCQX: KHRNF) (Frankfurt: A2JMZC), the global medical cannabis leader expanding throughout Europe and Latin America, continues to demonstrate its market dominance in the UK’s medical cannabis industry with cannabis sales volume growth of 240% in Q1 2022 compared to the entire 2021 year.
- Press releases
MGC Pharma Patent Application For CannEpil Drug Delivery System Granted By European IP Office
MGC Pharmaceuticals Ltd (ASX, LSE: MXC, ‘MGC Pharma’ or ‘the Company’), a European based bio-pharma company specialising in the production and development of phytomedicines, is pleased to announce that the Slovenian Intellectual Product Office (SIPO) has granted a patent for the Company’s Drug Delivery System of self-nanoemulsifying drug delivery system (SNEDDS) in Ionic Complex Concentrate (CannEpil®-IL).
- Press releases
PharmaCielo Partners With Soteria Holdings Limited To License, Import And Wholesale Its Medical Cannabis Flower And Extracts In The Polish Market
PHARMACIELO Ltd. (“PharmaCielo” or the “Company”) (TSXV: PCLO) (OTCQX: PCLOF), the Canadian parent of Colombia’s premier cultivator and producer of dried flower and medicinal-grade cannabis extracts, PharmaCielo Colombia Holdings S.A.S. (“Holdings”), today announced that it has signed an investment agreement (the “Agreement”) with Soteria Holdings Limited (“Soteria”), a UK based portfolio company of Artemis Growth Partners, an…
- Press releases
Apollon Formularies plc Acquires Intellectual Property From Aion Therapeutic
APOLLON Formularies plc (AQSE: APOL) (“Apollon” or the “Company”), a UK based international pharmaceutical company trading on the Aquis Stock Exchange, and Aion Therapeutic Inc.
- Press releases
HempStreet Announces Partnership With MGC Pharma To Revolutionise Global Phytomedicine Sector
MGC Pharmaceuticals Ltd (‘MGC Pharma’ or ‘the Company‘), a European based bio-pharma company specialising in the production and development of phytomedicines, is pleased to announce a partnership with HempStreet, India’s first research to retail venture in the medicinal cannabis sector.
- Press releases
Curaleaf International Announces Landmark Registration of Proprietary Range of Cannabis Products in Malta
CURALEAF International (the “Company”) part of Curaleaf Holdings (CNSX:CURA), Europe’s largest vertically integrated cannabis company, is pleased to announce the successful license of the Company’s range of cannabis based medicines as extract, under the name Adven, in Malta.
- Press releases
Cheerful Buddha CBD Products First Of Their Kind Stocked In Major Retailers – Achieve Landmark FSA Listing
CHEERFUL Buddha is the first CBD coffee & CBD Chocolate brand stocked in major retailers – including Holland & Barrett & WHSmith Travel – to make the UK Food Standards Agency CBD Novel Food Public List.
- Press releases
Cellular Goods Announces First Patent Application For Skin Brightening Innovation
CELLULAR Goods (LSE: CBX), a UK-based wellness company that provides premium consumer products formulated with lab-made cannabinoids, is pleased to announce the filing of its first patent application related to the use of cannabinoids for skin brightening.
- Press releases
Update: Almost 2500 Additional CBD Products Added To The Public List
ALMOST 2,500 new CBD products have been added to the Food Standards Agency’s (FSA) public list this week.
- Press releases
Former Clinton Advisor Joins FoliuMed Advisory Board
FOLIUMED, a medical cannabis company with manufacturing and R&D in Germany and cultivation in South America, is pleased to announce the appointment of Howard M.
- Pharmaceutical
Oxford Cannabinoid Technologies Announces Formation of Scientific Advisory Board to Support Clinical Strategy
OXFORD Cannabinoid Technologies Holdings plc (LSE: OCTP, OTCQB: OCTHF), the pharmaceutical company developing prescription cannabinoid medicines targeting the US$ multi-billion pain market is pleased to announce the formation of its Scientific Advisory Board (“SAB”).
- Press releases
SynBiotic SE & Enchilada Group: Joint Venture To Launch First Cannabis Store In Germany
WHAT will the sale of cannabis products for recreational use look like in Germany?
